NsGene's Grant

NsGene raised a round of funding on November 26, 2013. Investors include Karin & Sten Mortstedt CBD Solutions.

NsGene, a biotech company based in Denmark and Providence, will develop its BrainRepair platform to treat cortico-basal degeneration, a rare neurological disorder with symptoms similar to Parkinson's …

Articles about NsGene's Grant: